XIIDRA
XIIDRA
Approved
DIN Number
02471027
Drug Class
Human
Market Date
Feb 12, 2018
Company
HC
bausch & lomb inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02471027
AIG Number0159830001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01XA25 LIFITEGRAST
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LIFITEGRASTActive
Strength: 5 % / W/V
Monograph: LIFITEGRAST